Causalus Overview
- Year Founded
-
2018

- Status
-
Out of Business
- Employees
-
11

- Latest Deal Type
-
Out of Business
Causalus General Information
Description
Developer of medical software designed to support drug evaluation and monitoring. The company's software distinguishes and visualizes symptoms caused by drugs and the actual illness, medication follow-up, and standardized drug therapy, enabling elderly patients to get minimized the harmful adverse effects of medication.
Contact Information
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Outcome Management (Healthcare)
Other Healthcare Services
Primary Office
- Maria 01 Campus
- Lapinlahdenkatu 16
- 00180 Helsinki
- Finland
Causalus Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 00000 | Completed | Out of Business | |||
2. Secondary Transaction - Private | 31-May-2022 | 00000 | Completed | Generating Revenue | ||
1. Seed Round | 05-Dec-2018 | $389K | $389K | 00.000 | Completed | Startup |
Causalus Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 |
Causalus Patents
Causalus Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190259482-A1 | System and method of determining a prescription for a patient | Inactive | 20-Feb-2018 | 000000000 | 00 |
US-20210035671-A1 | System and method of determining a prescription for a patient | Pending | 20-Feb-2018 | 000000000 | 0 |